CRL stock · DCGO stock

CRL vs DCGO · rev $2.00B vs rev $73.4M

Charles River Laboratories (CRL) versus DocGo Inc (DCGO) — a side-by-side from cached financials, not a winner call.

Charles River Laboratories (CRL) is a diagnostics & research company listed on US.

DocGo Inc (DCGO) is a medical care facilities company listed on US.

Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.

Latest reported DCGO revenue for 2026-06-30 was $73.4M. Net income was -$15.8M. Revenue was down 2.8% from 2026-03-31 to 2026-06-30. DCGO currently screens at market cap $62.7M.

CRL currently screens at market cap $7.78B. DCGO currently screens at market cap $62.7M.

Not investment advice. Open the CRL and DCGO stock pages for the full models.

Not investment advice.

Popular Stock Comparisons